GO:0019075 virus maturation: Structural Transition Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019075 virus maturation is the biological process of refolding and structural rearrangement of virion parts that converts an intermediate virion into a mature, infectious virion.
• Maturation typically involves proteolytic cleavage of capsid or envelope proteins and conformational changes that stabilize the particle.
• Maturation can occur inside the host cell or after release, and is often the final step that renders a virus infectious.
• Key viral proteins such as flavivirus prM/E, retroviral Gag, and vaccinia core proteins are common drivers of maturation.
• Defects in maturation can block infectivity, making this process a target for antiviral strategies and vaccine design.
• Studying virus maturation requires structural, biochemical, and genetic tools including cryo-EM, proteomics, and CRISPR-based gene editing.
Description
Virus maturation (GO:0019075) is a critical late step in the viral life cycle in which an initially assembled, often non-infectious intermediate virion undergoes refolding and structural rearrangements to become a mature, infectious particle. This process is distinct from assembly and egress and is frequently triggered by proteolytic cleavage of viral structural proteins, which acts as a molecular switch to drive conformational changes. Maturation is observed across diverse viruses, including flaviviruses, retroviruses, and large DNA viruses such as vaccinia. Because maturation is often the final determinant of infectivity, it represents a key checkpoint for understanding viral pathogenesis and for developing antiviral interventions. Research on virus maturation has revealed that it can occur inside the host cell or after release, and that the precise timing and location are virus-specific. For example, flaviviruses mature in the trans-Golgi network, where low pH triggers rearrangement of the envelope proteins, while retroviruses mature after budding, following cleavage of the Gag polyprotein. These examples illustrate the diversity of mechanisms that fall under GO:0019075. Understanding virus maturation is essential for virologists, structural biologists, and drug developers because it links molecular events to the acquisition of infectivity. This article provides a research-grade overview of the ontology term, its molecular players, regulatory aspects, disease relevance, and experimental methods, with a focus on how CRISPR-based models can accelerate discovery.
virus maturation At A Glance
| GO ID | GO:0019075 |
|---|---|
| GO term | virus maturation |
| Ontology | biological_process |
| Synonym | bacteriophage maturation; viral maturation |
| Major function | Refolding and structural rearrangement of virion components to produce a mature, infectious virion |
| Common triggers | Proteolytic cleavage, pH changes, and allosteric switches in viral structural proteins |
| Location | Inside the host cell (e.g., secretory pathway) or after release (e.g., extracellular maturation) |
| Key examples | Flavivirus prM cleavage, retroviral Gag processing, vaccinia core maturation |
What Is GO:0019075?
According to the Gene Ontology, virus maturation (GO:0019075) is defined as the refolding and structural rearrangements of virion parts to transition from the intermediate virion to the more mature virion. Maturation usually involves proteolysis events and changes in the folding of the virion proteins. This process can occur inside the host cell or after release. In simpler terms, it is the set of molecular changes that turn a newly built virus particle into a fully infectious one.
Why Is virus maturation Important in Cell Biology?
Virus maturation is a decisive step in the viral life cycle because it converts a non-infectious or partially infectious intermediate into a fully infectious virion. This process is often the target of neutralizing antibodies and antiviral drugs, and its inhibition can block viral spread. Moreover, maturation defects can lead to the release of non-infectious particles, which has implications for vaccine development and for understanding viral pathogenesis. Studying virus maturation also provides fundamental insights into protein folding, proteolytic regulation, and macromolecular assembly.
• Maturation is required for infectivity in many enveloped and non-enveloped viruses.
• Proteolytic cleavage during maturation is a common mechanism that can be targeted by protease inhibitors.
• Flavivirus maturation involves pH-dependent rearrangement of prM and E proteins, which is critical for virion stability and entry.
• Vaccinia virus maturation involves complex core protein processing and is essential for forming infectious intracellular mature virions.
• Defects in maturation can result in non-infectious particles, which are being explored as vaccine candidates.
• Maturation is a dynamic process that can be studied using time-resolved structural techniques.
• Allosteric switches in viral capsid proteins regulate the timing of maturation.
• Plant-expressed virus-like particles can model maturation of eukaryotic viruses, providing scalable systems for study.
• Maturation of macropinosomes is required for vaccinia virus infection, linking cellular maturation pathways to viral entry.
• Understanding maturation can inform the design of broad-spectrum antivirals that target conserved structural transitions.
What Happens During virus maturation?
Proteolytic Cleavage of Structural Proteins
In simple terms: Maturation often starts when a viral enzyme cuts other viral proteins, like snipping a thread to let a structure change shape.
A hallmark of virus maturation is the proteolytic cleavage of precursor structural proteins, which acts as a molecular switch to trigger conformational changes. In retroviruses, the Gag polyprotein is cleaved by the viral protease after budding, leading to condensation of the capsid core and acquisition of infectivity. In flaviviruses, the precursor membrane protein prM is cleaved by furin in the trans-Golgi network, allowing the envelope protein E to rearrange into its mature fusogenic form. Vaccinia virus maturation involves proteolytic processing of core proteins, which is necessary for the formation of infectious intracellular mature virions. These cleavage events are often irreversible and serve as timing mechanisms for maturation.
Conformational Rearrangement and Refolding
In simple terms: After cleavage, the viral proteins change shape, like a lock clicking into place, to form a stable and infectious particle.
Following proteolysis, virion proteins undergo extensive refolding and structural rearrangements that stabilize the particle and prime it for entry. In flaviviruses, the E protein dimers rearrange from a flat, immature conformation to a more compact, mature conformation that is fusion-competent. The collapse model of flavivirus maturation proposes that the immature virion collapses into the mature form upon prM cleavage and pH change. In bacteriophages, maturation involves large-scale conformational changes in the capsid protein that increase stability and infectivity. These rearrangements are often guided by electrostatic and mechanical forces within the virion.
Allosteric Regulation and Molecular Switches
In simple terms: Some viral proteins act like switches that sense the right moment to change shape and trigger maturation.
Virus maturation is often controlled by allosteric molecular switches within the virion proteins, which respond to environmental cues such as pH, ion concentration, or binding to receptors. These switches ensure that maturation occurs at the correct time and place, preventing premature or aberrant structural changes. For example, the flavivirus E protein undergoes a pH-dependent allosteric transition that drives maturation in the secretory pathway. In vaccinia virus, the maturation of macropinosomes is required for infection, indicating that cellular allosteric factors can influence viral maturation. Understanding these switches provides opportunities for antiviral intervention.
Maturation Inside the Host Cell vs. After Release
In simple terms: Some viruses mature inside the cell before they leave, while others mature after they are released, like a fruit ripening after being picked.
The location of maturation varies among viruses. Flaviviruses mature inside the host cell, specifically in the trans-Golgi network, before being released. In contrast, retroviruses and many other enveloped viruses mature after budding from the plasma membrane, when the viral protease cleaves Gag and triggers core condensation. Vaccinia virus maturation occurs intracellularly, where immature virions transition into intracellular mature virions. The timing and location of maturation are critical for infectivity and are often regulated by host factors. Plant-expressed virus-like particles have been used to study the intricate maturation process of a eukaryotic virus, demonstrating that maturation can be recapitulated in heterologous systems.
Structural Transition and Stabilization
In simple terms: The final step of maturation locks the virus into a stable shape that can survive outside the cell and infect a new one.
The ultimate outcome of virus maturation is a stabilized virion that is resistant to environmental stresses and competent for entry. This stabilization often involves the formation of new protein-protein interfaces and the rearrangement of capsid or envelope proteins. In T=4 quasi-equivalent viruses, electrostatic and mechanical forces guide the maturation process to produce a stable capsid. In flaviviruses, the mature virion is more compact and less prone to premature fusion. The structural transition is often irreversible, ensuring that the virus remains infectious. Defects in this stabilization step can lead to non-infectious particles.
Key Genes Involved in GO:0019075 virus maturation
The following genes and proteins are key players in virus maturation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| prM (flavivirus) | Precursor membrane protein; cleaved by furin to allow E protein rearrangement | Target for flavivirus maturation inhibitors and vaccine design |
| E (flavivirus) | Envelope protein; undergoes pH-dependent conformational change during maturation | Key determinant of infectivity and fusion; studied by cryo-EM |
| Gag (retrovirus) | Polyprotein cleaved by viral protease to form mature capsid core | Model for proteolytic maturation and allosteric switches |
| Protease (retrovirus) | Viral protease that cleaves Gag during maturation | Target of antiretroviral drugs; studied for specificity |
| Core proteins (vaccinia) | Structural proteins processed during virion maturation | Essential for infectious intracellular mature virion formation |
| A17 (vaccinia) | Membrane protein involved in virion assembly and maturation | Studied for role in maturation and entry |
| D13 (vaccinia) | Scaffold protein required for immature virion formation | Target for assembly and maturation studies |
| Capsid protein (bacteriophage) | Major structural protein that undergoes conformational changes during maturation | Model for studying maturation dynamics |
| Scaffold protein (bacteriophage) | Assists in capsid assembly and is removed during maturation | Studied for allosteric regulation |
| Maturation protease (flavivirus) | NS2B-NS3 protease involved in polyprotein processing | Antiviral target; role in maturation |
| Furin (host) | Host protease that cleaves prM during flavivirus maturation | Host factor for maturation; potential target |
| E1/E2 (alphavirus) | Envelope glycoproteins that undergo maturation cleavage | Model for enveloped virus maturation |
| VP0 (picornavirus) | Capsid precursor cleaved during maturation | Studied for maturation-dependent infectivity |
| VP4 (picornavirus) | Internal capsid protein released during maturation | Role in entry and maturation |
| Maturation protein (plant virus) | Movement protein or coat protein involved in maturation | Studied using plant-expressed VLPs |
| Macropinosome maturation factors (host) | Host proteins required for macropinosome maturation during vaccinia entry | Link between cellular maturation and viral infection |
| T=4 capsid protein | Quasi-equivalent capsid protein guided by electrostatic forces | Model for physical forces in maturation |
| Envelope protein (tick-borne encephalitis virus) | Structural protein that rearranges during maturation | Studied by cryo-EM to support collapse model |
How Is virus maturation Regulated?
Virus maturation is regulated at multiple levels, including proteolytic activation, pH-dependent conformational switches, and allosteric control by viral or host factors. In flaviviruses, the low pH of the trans-Golgi network triggers the cleavage of prM by furin and the subsequent rearrangement of E protein, acting as a spatial and temporal regulator. In retroviruses, the viral protease is activated upon budding, ensuring that maturation occurs after release from the host cell. Host factors such as furin and macropinosome maturation machinery can also regulate viral maturation. Additionally, electrostatic and mechanical forces within the virion can guide the structural transition, as shown for T=4 quasi-equivalent viruses. These regulatory mechanisms ensure that maturation is tightly coupled to the viral life cycle and environmental cues.
virus maturation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| prM (flavivirus) | Zika, dengue, tick-borne encephalitis | Knockout of furin in host cells; point mutations in prM cleavage site |
| Gag (retrovirus) | HIV/AIDS | Point mutations in Gag cleavage sites; protease inhibitors |
| Core proteins (vaccinia) | Vaccinia virus infection | Knockout of core protein genes; inducible expression |
| Furin (host) | Flavivirus maturation | CRISPR knockout of furin in cell lines; rescue with wild-type |
| Macropinosome maturation factors | Vaccinia virus entry | Knockout of host genes; small molecule inhibitors |
Flavivirus Infections (Zika, Dengue, Tick-Borne Encephalitis)
Flavivirus maturation is essential for the production of infectious virions and is a determinant of pathogenesis. In Zika virus, maturation involves the cleavage of prM and rearrangement of E protein, which affects receptor binding and entry. The collapse model of flavivirus maturation, supported by structural studies of tick-borne encephalitis virus, provides a framework for understanding how maturation defects can lead to non-infectious particles. These insights are relevant for vaccine development and antiviral targeting.
Retroviral Infections (HIV)
Retroviral maturation is a paradigm for proteolytic processing and allosteric regulation. In HIV, the cleavage of Gag by the viral protease is required for the formation of an infectious core. Inhibitors of the viral protease are effective antiretrovirals, highlighting the therapeutic importance of maturation. Allosteric molecular switches in Gag regulate the timing of maturation, and mutations that disrupt this process can block infectivity.
Poxvirus Infections (Vaccinia)
Vaccinia virus maturation is a complex process involving the processing of core proteins and the formation of intracellular mature virions. Defects in maturation lead to the accumulation of immature virions and loss of infectivity. Additionally, vaccinia virus infection requires the maturation of macropinosomes, a host cellular process, illustrating the interplay between viral and host maturation pathways. Understanding these processes can inform the development of antivirals and vaccine vectors.
From virus maturation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a specific cleavage site in prM regulate flavivirus maturation? | Point mutation (cleavage site mutant) in prM |
| Is furin required for flavivirus maturation? | Knockout of furin in host cells |
| How does Gag cleavage affect retroviral core stability? | Point mutation in Gag cleavage sites |
| What is the role of vaccinia core protein in maturation? | Knockout or inducible knockdown of core protein |
| Can maturation be visualized in real time? | Tagged knock-in of viral structural proteins with fluorescent tags |
| Does overexpression of a viral protease enhance maturation? | Overexpression of viral protease in producer cells |
How to Study the virus maturation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | High-resolution structure of virions at different maturation stages | Visualizing conformational changes in flaviviruses |
| Mass spectrometry | Cleavage sites and protein processing | Mapping Gag cleavage in retroviruses |
| Plaque assay | Infectivity of released virions | Assessing the effect of maturation inhibitors |
| Western blot | Presence of cleaved vs. uncleaved viral proteins | Monitoring maturation in cell lysates |
| Fluorescence microscopy | Localization and dynamics of tagged viral proteins | Live-cell imaging of maturation |
| Virus-like particle (VLP) production | Assembly and maturation of non-infectious particles | Modeling maturation in plant or mammalian cells |
| Macropinosome maturation assay | Host cellular maturation during viral entry | Studying vaccinia virus infection |
| Allosteric switch assays | Conformational changes in response to ligands or pH | Characterizing molecular switches in capsid proteins |
Structural Biology (Cryo-EM and X-ray Crystallography)
Cryo-electron microscopy and X-ray crystallography are essential for visualizing the conformational changes that occur during virus maturation. These techniques have revealed the structural transitions of flavivirus E protein and the collapse model of maturation. Time-resolved cryo-EM can capture intermediate states, providing dynamic insights.
Proteomics and Mass Spectrometry
Proteomics can identify cleavage events and post-translational modifications that occur during maturation. Mass spectrometry-based approaches can map the precise cleavage sites in viral polyproteins, such as Gag or prM. This is critical for understanding the order and timing of maturation steps.
Infectivity Assays and Plaque Reduction
Infectivity assays measure the production of mature, infectious virions and are used to assess the impact of mutations or inhibitors on maturation. Plaque reduction assays can quantify the effect of antiviral compounds that target maturation.
Fluorescence Microscopy and Live-Cell Imaging
Fluorescently tagged viral proteins can be used to track maturation in live cells, revealing the timing and location of structural changes. This approach has been used to study the maturation of vaccinia virus and other large DNA viruses.
How CRISPR Can Be Used to Study GO:0019075 virus maturation
Knockout
CRISPR knockout of host genes required for virus maturation, such as furin, can reveal essential host factors and block the production of infectious virions. Knockout of viral genes is also possible using CRISPR in the context of viral genomes, though this is more challenging. Knockout studies have been used to demonstrate the requirement for macropinosome maturation in vaccinia infection.
Point Mutation
CRISPR-based point mutations can be introduced into viral or host genes to study the role of specific cleavage sites or allosteric residues in maturation. For example, mutating the prM cleavage site in flaviviruses can prevent maturation and reduce infectivity. Point mutations in Gag cleavage sites can block retroviral maturation.
Knock-in
Knock-in of tagged viral structural proteins (e.g., fluorescent tags) allows real-time visualization of maturation in living cells. Knock-in of reporter genes under the control of viral promoters can also be used to monitor maturation-dependent gene expression. This approach is valuable for high-content screening.
Overexpression
Overexpression of viral proteases or structural proteins can drive or enhance maturation in producer cells, facilitating biochemical studies. Overexpression of host factors like furin can also increase maturation efficiency. This approach is useful for producing large quantities of mature virions for structural studies.
How EDITGENE Supports virus maturation Research
Researchers studying virus maturation-related genes often need to determine whether a candidate gene is causally involved in the maturation process or is merely correlated with it. CRISPR-based gene editing provides a precise way to test causality by introducing targeted knockouts, point mutations, knock-ins, or overexpression constructs in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for virus maturation research.
Frequently Asked Questions About virus maturation
What is virus maturation (GO:0019075)?
Virus maturation is the biological process in which an intermediate virion undergoes refolding and structural rearrangements to become a mature, infectious virion, often involving proteolysis and conformational changes.
What genes are involved in virus maturation?
Key genes include flavivirus prM and E, retroviral Gag and protease, vaccinia core proteins, and host factors such as furin.
Where does virus maturation occur?
Maturation can occur inside the host cell, such as in the trans-Golgi network for flaviviruses, or after release, as seen in retroviruses.
Why is virus maturation important for infectivity?
Maturation converts non-infectious or partially infectious particles into fully infectious virions, often by stabilizing the capsid or envelope and priming entry.
What is the role of proteolysis in virus maturation?
Proteolytic cleavage of precursor proteins acts as a molecular switch that triggers conformational changes required for maturation.
How is virus maturation studied?
Common methods include cryo-EM, mass spectrometry, infectivity assays, and fluorescence microscopy, often combined with CRISPR-based gene editing.
What diseases are associated with defects in virus maturation?
Defects can reduce infectivity and are studied in flavivirus, retrovirus, and poxvirus infections, with implications for antiviral and vaccine development.
Can CRISPR be used to study virus maturation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of viral and host genes involved in maturation.
What is the collapse model of flavivirus maturation?
The collapse model proposes that the immature flavivirus particle collapses into the mature form upon prM cleavage and pH change, as supported by structural studies.
How does vaccinia virus maturation differ from other viruses?
Vaccinia virus maturation involves complex core protein processing and occurs intracellularly, and it also requires host macropinosome maturation for infection.
Conclusion
Virus maturation (GO:0019075) is a fundamental biological process that bridges viral assembly and infectivity. It encompasses proteolytic cleavage, conformational rearrangements, and allosteric regulation, often guided by host and viral factors. Understanding maturation mechanisms is crucial for developing antiviral therapies and vaccines, as highlighted by studies on flaviviruses, retroviruses, and poxviruses. CRISPR-based gene editing offers powerful tools to dissect the genetic requirements of maturation, and EDITGENE provides comprehensive services to support such research.
References
- 1. Sirohi D et al.. 2017. Zika Virus Structure, Maturation, and Receptors.. J Infect Dis 216(suppl_10):S935-S944 PMID: 29267925
- 2. Domitrovic T et al.. 2013. Virus assembly and maturation: auto-regulation through allosteric molecular switches.. J Mol Biol 425(9):1488-96 PMID: 23485419
- 3. Anastasina M et al.. 2024. The structure of immature tick-borne encephalitis virus supports the collapse model of flavivirus maturation.. Sci Adv 10(27):eadl1888 PMID: 38959313
- 4. Liu L et al.. 2014. From crescent to mature virion: vaccinia virus assembly and maturation.. Viruses 6(10):3787-808 PMID: 25296112
- 5. Steven AC et al.. 2005. Virus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity.. Curr Opin Struct Biol 15(2):227-36 PMID: 15837183
- 6. Kearney BM et al.. 2014. Assembly and maturation of a T = 4 quasi-equivalent virus is guided by electrostatic and mechanical forces.. Viruses 6(8):3348-62 PMID: 25153346
- 7. Castells-Graells R et al.. 2021. Plant-expressed virus-like particles reveal the intricate maturation process of a eukaryotic virus.. Commun Biol 4(1):619 PMID: 34031522
- 8. Rizopoulos Z et al.. 2015. Vaccinia Virus Infection Requires Maturation of Macropinosomes.. Traffic 16(8):814-31 PMID: 25869659
